JPRN-UMIN000005973已完成未知
Tadalafil study for pediatric PAH on efficacy, safety and pharmacodynamics - Tadalafil study for pediatric PAH
ational Cerebral and Cardiovascular Center0 个研究点目标入组 10 人开始时间: 2011年8月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 18years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Those who are contraindicated for tadalafil
研究者
相似试验
已完成
3 期
A Study of Tadalafil in Pediatric Participants With Pulmonary Arterial Hypertension (PAH)Hypertension, PulmonaryNCT01824290Eli Lilly and Company35
招募中
2 期
Tadalafil for fetus with early-onset growth restriction (TADAFER IIb)Fetal growth restrictionFetal growth restriction, PDE5 inhibitorJPRN-jRCTs041190065Maki Shintaro180
招募中
不适用
Tadalafil for painful bladderCTRI/2018/03/012720Dr Gajanan Bhat
尚未招募
4 期
A study to compare the beneficial effect and safety of tadalafil compared to sildenafil in pulmonary hypertensive patients due to lung diseaseCTRI/2024/06/069470Midhun Sakravarthy J
已完成
不适用
The effect of tadalafil compared to tamsulosin and placebo on the symptoms of double-J stent insertion in men with ureter stonesCondition 1: Lower urinary tract symptoms. Condition 2: Pain in the flank and suprapubic areas. Condition 3: Sexual function.Calculus of lower urinary tractOther and unspecified abdominal painUnspecified sexual dysfunction, not caused by organic disorder or diseaseIRCT201702261853N13rology Research Centre, Guilan University of Medical Sciences120